ReviewTargeted oncology2026

CDK4/6 Inhibitors in Breast Cancer Therapy: Mechanisms, Resistance, and Emerging Opportunities.

Luis Chinea et al.PubMed ↗Publisher ↗

No numbers read from the abstract.